Mar 09, 2019 · Noble Financial's Ahu Demir reiterated an Outperform rating on TrovaGene and lowered the price target from $27 to $20, incorporating the recent reverse stock split and data readouts. BIO-PATH HOLDINGS, INC. : BPTH Stock Price | MarketScreener Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Bio-Path Holdings, Inc. (BPTH) Stock Price, Quote, History ...
Nov 06, 2019 · Bio-Path Holdings Inc. analyst estimates by MarketWatch. View BPTH revenue estimates and earnings estimates, as well as analyst recommendations.
Analyst Actions: HC Wainwright Cuts Bio-Path Holdings Price Target to $25 From $28, Maintains Buy Rating 11:59AM ET 12/02/2019 MT Newswires. Bio-Path Holdings' (BPTH) average rating among analysts is a buy, with an average price target of $25. ROKU Price Target | Roku Stock Forecast & Ratings See Roku price target based on 10 analysts offering 12 month price targets for Roku in the last 3 months. The average price target is $131.10 with a high forecast of $200.00 and a low forecast of $60.00. The average price target represents a 58.85% increase from the last price of $82.53. BPTH Stock Price & Charts | Bio-Path Holdings In depth view into BPTH (Bio-Path Holdings) stock including the latest price, news, dividend history, earnings information and financials. BPTH Stock - Bio-Path Holdings - Buy, Sell, or Hold
BPTH Price Target and Analyst Ratings (Bio-Path) | MarketBeat
View the latest Bio-Path Holdings Inc. (BPTH) stock price, news, historical charts, analyst ratings and financial information from WSJ. BPTH Stock Price and Chart — NASDAQ:BPTH — TradingView View live BIO-PATH HOLDINGS INC chart to track its stock's price action. Find market predictions, BPTH financials and market news. Bio-Path Holdings, Inc. Common Stock (BPTH) Stock Quotes ... Bio-Path Holdings, Inc. Common Stock (BPTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Bio-Path Holdings, Inc. Common Stock (BPTH) Analyst ...
BPTH Stock - Bio-Path Holdings - Buy, Sell, or Hold BPTH Analysis Overview . What this means: InvestorsObserver gives Bio-Path Holdings (BPTH) an overall rank of 40, which is below average. Bio-Path Holdings is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Bio-Path (BPTH) Stock: Here’s Why It’s Rocketing! | CNA ... Mar 01, 2019 · Bio-Path Holdings Inc (NASDAQ: BPTH) is rocketing in the market this morning, more than doubling in value. The gains come on the heals of a press release, announcing that the company will be … BPTH Split History Bio-Path Holdings (BPTH) has 2 splits in our BPTH split history database. The first split for BPTH took place on February 09, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of BPTH owned pre-split, the shareholder now owned 1 share.
View the latest Bio-Path Holdings Inc. (BPTH) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Their average twelve-month price target is $25.00, suggesting that the stock has a possible upside of 633.14%. The high price target for BPTH is $25.00 and the Based on 1 Wall Street analysts offering stock ratings for Bio-Path Holdings in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Top Analysts Based on analysts offering 12 month price targets for BPTH in the last 3 months. The average price target is $0.00 with a high estimate of $0.00 and a low Average Recommendation: Buy, Average Target Price: 25.00. Number of Ratings : 1, Current Quarters Estimate: -0.69. FY Report Date: 12 / 2019, Current Year's BPTH | Complete Bio-Path Holdings Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview. Bio-Path Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BPTH updated stock price target summary.
The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a The current consensus among 1 polled investment analysts is to Buy stock in